Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Suzanne R Hayman

Showing results (1-10 of 242) with videos related to

Pageof 25
Sort By:
Nature Clinical Practice. Nephrology|October 25, 2007
Hypertension in pregnancy: an emerging risk factor for cardiovascular diseaseVesna D Garovic, Suzanne R Hayman
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapyTaimur Sher, Suzanne R Hayman, Morie A Gertz
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
IgM amyloidosis: clinical features in therapeutic outcomesMorie A Gertz, Francis K Buadi, Suzanne R Hayman
Clinical Lymphoma & Myeloma|April 14, 2009
Transplantation for IgM amyloidosis and IgM myelomaMorie A Gertz, Suzanne R Hayman, Francis K Buadi
Oncology (Williston Park, N.Y.)|September 6, 2011
Treatment of immunoglobulin light chain (primary or AL) amyloidosisMorie A Gertz, Francis K Buadi, Suzanne R Hayman
Clinical Lymphoma & Myeloma|December 16, 2005
Amyloidosis: diagnosis and managementMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Current Oncology Reports|May 1, 2012
VEGF inhibition, hypertension, and renal toxicitySuzanne R Hayman, Nelson Leung, Joseph P Grande, et al.
Best Practice & Research. Clinical Haematology|July 20, 2005
AmyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Women'S Health (London, England)|December 17, 2008
Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular diseaseIasmina M Craici, Steven J Wagner, Suzanne R Hayman, et al.
Current Opinion in Oncology|February 3, 2007
Transplantation for amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Pageof 25

Showing results (1-10 of 242) with videos related to

Sort By:
Pageof 25
Nature Clinical Practice. Nephrology|October 25, 2007
Hypertension in pregnancy: an emerging risk factor for cardiovascular diseaseVesna D Garovic, Suzanne R Hayman
Clinical Advances in Hematology & Oncology : H&O|November 29, 2012
Treatment of primary systemic amyloidosis (AL): role of intensive and standard therapyTaimur Sher, Suzanne R Hayman, Morie A Gertz
Clinical Lymphoma, Myeloma & Leukemia|April 2, 2011
IgM amyloidosis: clinical features in therapeutic outcomesMorie A Gertz, Francis K Buadi, Suzanne R Hayman
Clinical Lymphoma & Myeloma|April 14, 2009
Transplantation for IgM amyloidosis and IgM myelomaMorie A Gertz, Suzanne R Hayman, Francis K Buadi
Oncology (Williston Park, N.Y.)|September 6, 2011
Treatment of immunoglobulin light chain (primary or AL) amyloidosisMorie A Gertz, Francis K Buadi, Suzanne R Hayman
Clinical Lymphoma & Myeloma|December 16, 2005
Amyloidosis: diagnosis and managementMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Current Oncology Reports|May 1, 2012
VEGF inhibition, hypertension, and renal toxicitySuzanne R Hayman, Nelson Leung, Joseph P Grande, et al.
Best Practice & Research. Clinical Haematology|July 20, 2005
AmyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Women'S Health (London, England)|December 17, 2008
Pre-eclamptic pregnancies: an opportunity to identify women at risk for future cardiovascular diseaseIasmina M Craici, Steven J Wagner, Suzanne R Hayman, et al.
Current Opinion in Oncology|February 3, 2007
Transplantation for amyloidosisMorie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Pageof 25